nodes	percent_of_prediction	percent_of_DWPC	metapath
Succinylcholine—BCHE—Ramipril—type 2 diabetes mellitus	0.243	1	CbGbCtD
Succinylcholine—Porphyrin metabolism disorder—Gliclazide—type 2 diabetes mellitus	0.0231	0.0509	CcSEcCtD
Succinylcholine—Pulmonary oedema—Rosiglitazone—type 2 diabetes mellitus	0.00712	0.0157	CcSEcCtD
Succinylcholine—Anaphylactoid reaction—Repaglinide—type 2 diabetes mellitus	0.00635	0.014	CcSEcCtD
Succinylcholine—Hypertonia—Glipizide—type 2 diabetes mellitus	0.00614	0.0135	CcSEcCtD
Succinylcholine—Pulmonary oedema—Pioglitazone—type 2 diabetes mellitus	0.00597	0.0132	CcSEcCtD
Succinylcholine—Renal failure acute—Sitagliptin—type 2 diabetes mellitus	0.00512	0.0113	CcSEcCtD
Succinylcholine—Rhabdomyolysis—Valsartan—type 2 diabetes mellitus	0.00503	0.0111	CcSEcCtD
Succinylcholine—Salivary hypersecretion—Gliclazide—type 2 diabetes mellitus	0.0047	0.0104	CcSEcCtD
Succinylcholine—Ventricular fibrillation—Losartan—type 2 diabetes mellitus	0.0047	0.0104	CcSEcCtD
Succinylcholine—Hyperkalaemia—Valsartan—type 2 diabetes mellitus	0.00437	0.00963	CcSEcCtD
Succinylcholine—Rhabdomyolysis—Irbesartan—type 2 diabetes mellitus	0.00432	0.00952	CcSEcCtD
Succinylcholine—Renal failure acute—Glyburide—type 2 diabetes mellitus	0.00424	0.00934	CcSEcCtD
Succinylcholine—Rhabdomyolysis—Losartan—type 2 diabetes mellitus	0.00407	0.00896	CcSEcCtD
Succinylcholine—Myalgia—Linagliptin—type 2 diabetes mellitus	0.00389	0.00857	CcSEcCtD
Succinylcholine—Renal failure acute—Gliclazide—type 2 diabetes mellitus	0.00381	0.00839	CcSEcCtD
Succinylcholine—Arrhythmia—Repaglinide—type 2 diabetes mellitus	0.0038	0.00837	CcSEcCtD
Succinylcholine—Hyperkalaemia—Irbesartan—type 2 diabetes mellitus	0.00376	0.00828	CcSEcCtD
Succinylcholine—Anaphylactic shock—Linagliptin—type 2 diabetes mellitus	0.00373	0.00822	CcSEcCtD
Succinylcholine—Renal failure—Sitagliptin—type 2 diabetes mellitus	0.00358	0.0079	CcSEcCtD
Succinylcholine—Hyperkalaemia—Losartan—type 2 diabetes mellitus	0.00353	0.00779	CcSEcCtD
Succinylcholine—Renal failure acute—Valsartan—type 2 diabetes mellitus	0.0035	0.00771	CcSEcCtD
Succinylcholine—Pulmonary oedema—Irbesartan—type 2 diabetes mellitus	0.0034	0.0075	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Linagliptin—type 2 diabetes mellitus	0.0034	0.00749	CcSEcCtD
Succinylcholine—Bradycardia—Glimepiride—type 2 diabetes mellitus	0.00334	0.00736	CcSEcCtD
Succinylcholine—Urticaria—Tolbutamide—type 2 diabetes mellitus	0.00329	0.00725	CcSEcCtD
Succinylcholine—Flushing—Glipizide—type 2 diabetes mellitus	0.00326	0.00719	CcSEcCtD
Succinylcholine—Pulmonary oedema—Losartan—type 2 diabetes mellitus	0.0032	0.00706	CcSEcCtD
Succinylcholine—Hypertension—Repaglinide—type 2 diabetes mellitus	0.0032	0.00704	CcSEcCtD
Succinylcholine—Arrhythmia—Glipizide—type 2 diabetes mellitus	0.00314	0.00693	CcSEcCtD
Succinylcholine—Anaphylactic shock—Repaglinide—type 2 diabetes mellitus	0.00302	0.00666	CcSEcCtD
Succinylcholine—Hypertension—Rosiglitazone—type 2 diabetes mellitus	0.00302	0.00666	CcSEcCtD
Succinylcholine—Bradycardia—Bromocriptine—type 2 diabetes mellitus	0.00301	0.00664	CcSEcCtD
Succinylcholine—Salivary hypersecretion—Ramipril—type 2 diabetes mellitus	0.003	0.0066	CcSEcCtD
Succinylcholine—Urticaria—Chlorpropamide—type 2 diabetes mellitus	0.00299	0.0066	CcSEcCtD
Succinylcholine—Urticaria—Tolazamide—type 2 diabetes mellitus	0.00299	0.0066	CcSEcCtD
Succinylcholine—Myalgia—Rosiglitazone—type 2 diabetes mellitus	0.00298	0.00656	CcSEcCtD
Succinylcholine—Urticaria—Linagliptin—type 2 diabetes mellitus	0.00296	0.00653	CcSEcCtD
Succinylcholine—Arrhythmia—Glimepiride—type 2 diabetes mellitus	0.00293	0.00646	CcSEcCtD
Succinylcholine—Rash—Miglitol—type 2 diabetes mellitus	0.0029	0.0064	CcSEcCtD
Succinylcholine—Dermatitis—Miglitol—type 2 diabetes mellitus	0.0029	0.00639	CcSEcCtD
Succinylcholine—Urticaria—Acarbose—type 2 diabetes mellitus	0.00288	0.00634	CcSEcCtD
Succinylcholine—Anaphylactic shock—Rosiglitazone—type 2 diabetes mellitus	0.00285	0.00629	CcSEcCtD
Succinylcholine—Urticaria—Nateglinide—type 2 diabetes mellitus	0.00277	0.00611	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Repaglinide—type 2 diabetes mellitus	0.00275	0.00607	CcSEcCtD
Succinylcholine—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.00275	0.00605	CcSEcCtD
Succinylcholine—Bronchospasm—Orlistat—type 2 diabetes mellitus	0.00271	0.00598	CcSEcCtD
Succinylcholine—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.00267	0.00588	CcSEcCtD
Succinylcholine—Renal failure—Gliclazide—type 2 diabetes mellitus	0.00266	0.00587	CcSEcCtD
Succinylcholine—Arrhythmia—Bromocriptine—type 2 diabetes mellitus	0.00265	0.00583	CcSEcCtD
Succinylcholine—Hypertension—Glipizide—type 2 diabetes mellitus	0.00264	0.00583	CcSEcCtD
Succinylcholine—Rash—Tolbutamide—type 2 diabetes mellitus	0.00261	0.00575	CcSEcCtD
Succinylcholine—Myalgia—Glipizide—type 2 diabetes mellitus	0.00261	0.00575	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Rosiglitazone—type 2 diabetes mellitus	0.0026	0.00573	CcSEcCtD
Succinylcholine—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.00257	0.00567	CcSEcCtD
Succinylcholine—Hypertension—Pioglitazone—type 2 diabetes mellitus	0.00253	0.00558	CcSEcCtD
Succinylcholine—Myalgia—Pioglitazone—type 2 diabetes mellitus	0.0025	0.0055	CcSEcCtD
Succinylcholine—Bradycardia—Gliclazide—type 2 diabetes mellitus	0.00247	0.00545	CcSEcCtD
Succinylcholine—Hypertension—Glimepiride—type 2 diabetes mellitus	0.00247	0.00544	CcSEcCtD
Succinylcholine—Hypertension—Sitagliptin—type 2 diabetes mellitus	0.00246	0.00542	CcSEcCtD
Succinylcholine—Shock—Glipizide—type 2 diabetes mellitus	0.00246	0.00542	CcSEcCtD
Succinylcholine—Renal failure—Valsartan—type 2 diabetes mellitus	0.00245	0.00539	CcSEcCtD
Succinylcholine—Myalgia—Sitagliptin—type 2 diabetes mellitus	0.00243	0.00534	CcSEcCtD
Succinylcholine—Renal failure acute—Ramipril—type 2 diabetes mellitus	0.00242	0.00534	CcSEcCtD
Succinylcholine—Renal failure—Orlistat—type 2 diabetes mellitus	0.00242	0.00533	CcSEcCtD
Succinylcholine—Urticaria—Repaglinide—type 2 diabetes mellitus	0.0024	0.00529	CcSEcCtD
Succinylcholine—Anaphylactic shock—Pioglitazone—type 2 diabetes mellitus	0.00239	0.00528	CcSEcCtD
Succinylcholine—Rash—Chlorpropamide—type 2 diabetes mellitus	0.00238	0.00523	CcSEcCtD
Succinylcholine—Rash—Tolazamide—type 2 diabetes mellitus	0.00238	0.00523	CcSEcCtD
Succinylcholine—Rash—Linagliptin—type 2 diabetes mellitus	0.00235	0.00518	CcSEcCtD
Succinylcholine—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.00235	0.00518	CcSEcCtD
Succinylcholine—Anaphylactic shock—Glimepiride—type 2 diabetes mellitus	0.00233	0.00514	CcSEcCtD
Succinylcholine—Anaphylactic shock—Sitagliptin—type 2 diabetes mellitus	0.00232	0.00512	CcSEcCtD
Succinylcholine—Anaphylactoid reaction—Ramipril—type 2 diabetes mellitus	0.00231	0.0051	CcSEcCtD
Succinylcholine—Shock—Glimepiride—type 2 diabetes mellitus	0.00229	0.00506	CcSEcCtD
Succinylcholine—Rash—Acarbose—type 2 diabetes mellitus	0.00228	0.00503	CcSEcCtD
Succinylcholine—Dermatitis—Acarbose—type 2 diabetes mellitus	0.00228	0.00502	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Glipizide—type 2 diabetes mellitus	0.00228	0.00502	CcSEcCtD
Succinylcholine—Tachycardia—Glimepiride—type 2 diabetes mellitus	0.00228	0.00502	CcSEcCtD
Succinylcholine—Urticaria—Rosiglitazone—type 2 diabetes mellitus	0.00227	0.005	CcSEcCtD
Succinylcholine—Flushing—Gliclazide—type 2 diabetes mellitus	0.00226	0.00497	CcSEcCtD
Succinylcholine—Hypertension—Bromocriptine—type 2 diabetes mellitus	0.00223	0.00491	CcSEcCtD
Succinylcholine—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.00223	0.0049	CcSEcCtD
Succinylcholine—Rash—Nateglinide—type 2 diabetes mellitus	0.0022	0.00485	CcSEcCtD
Succinylcholine—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.0022	0.00484	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Pioglitazone—type 2 diabetes mellitus	0.00218	0.00481	CcSEcCtD
Succinylcholine—Hypotension—Glimepiride—type 2 diabetes mellitus	0.00218	0.0048	CcSEcCtD
Succinylcholine—Arrhythmia—Gliclazide—type 2 diabetes mellitus	0.00217	0.00479	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Sitagliptin—type 2 diabetes mellitus	0.00212	0.00467	CcSEcCtD
Succinylcholine—Renal failure—Irbesartan—type 2 diabetes mellitus	0.0021	0.00463	CcSEcCtD
Succinylcholine—Bradycardia—Metformin—type 2 diabetes mellitus	0.00207	0.00456	CcSEcCtD
Succinylcholine—Shock—Bromocriptine—type 2 diabetes mellitus	0.00207	0.00456	CcSEcCtD
Succinylcholine—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.00205	0.00453	CcSEcCtD
Succinylcholine—Myalgia—Glyburide—type 2 diabetes mellitus	0.00201	0.00442	CcSEcCtD
Succinylcholine—Urticaria—Glipizide—type 2 diabetes mellitus	0.00199	0.00438	CcSEcCtD
Succinylcholine—Renal failure—Losartan—type 2 diabetes mellitus	0.00198	0.00436	CcSEcCtD
Succinylcholine—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.00197	0.00433	CcSEcCtD
Succinylcholine—Bradycardia—Irbesartan—type 2 diabetes mellitus	0.00195	0.00431	CcSEcCtD
Succinylcholine—Rash—Repaglinide—type 2 diabetes mellitus	0.0019	0.0042	CcSEcCtD
Succinylcholine—Bronchospasm—Ramipril—type 2 diabetes mellitus	0.0019	0.00419	CcSEcCtD
Succinylcholine—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.0019	0.00419	CcSEcCtD
Succinylcholine—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.0019	0.00419	CcSEcCtD
Succinylcholine—Shock—Glyburide—type 2 diabetes mellitus	0.00189	0.00417	CcSEcCtD
Succinylcholine—Flushing—Metformin—type 2 diabetes mellitus	0.00189	0.00416	CcSEcCtD
Succinylcholine—Urticaria—Glimepiride—type 2 diabetes mellitus	0.00185	0.00408	CcSEcCtD
Succinylcholine—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.00185	0.00407	CcSEcCtD
Succinylcholine—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.00184	0.00406	CcSEcCtD
Succinylcholine—Hypertension—Gliclazide—type 2 diabetes mellitus	0.00183	0.00403	CcSEcCtD
Succinylcholine—Myalgia—Gliclazide—type 2 diabetes mellitus	0.0018	0.00397	CcSEcCtD
Succinylcholine—Rash—Rosiglitazone—type 2 diabetes mellitus	0.0018	0.00397	CcSEcCtD
Succinylcholine—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.0018	0.00396	CcSEcCtD
Succinylcholine—Hypotension—Glyburide—type 2 diabetes mellitus	0.0018	0.00396	CcSEcCtD
Succinylcholine—Flushing—Irbesartan—type 2 diabetes mellitus	0.00178	0.00393	CcSEcCtD
Succinylcholine—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.00176	0.00389	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.00175	0.00386	CcSEcCtD
Succinylcholine—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.00172	0.00379	CcSEcCtD
Succinylcholine—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.00171	0.00378	CcSEcCtD
Succinylcholine—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.00171	0.00377	CcSEcCtD
Succinylcholine—Renal failure—Ramipril—type 2 diabetes mellitus	0.0017	0.00374	CcSEcCtD
Succinylcholine—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.00169	0.00371	CcSEcCtD
Succinylcholine—Flushing—Losartan—type 2 diabetes mellitus	0.00168	0.00369	CcSEcCtD
Succinylcholine—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.00167	0.00368	CcSEcCtD
Succinylcholine—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.00166	0.00367	CcSEcCtD
Succinylcholine—Myalgia—Valsartan—type 2 diabetes mellitus	0.00166	0.00365	CcSEcCtD
Succinylcholine—Myalgia—Orlistat—type 2 diabetes mellitus	0.00164	0.0036	CcSEcCtD
Succinylcholine—Hypotension—Gliclazide—type 2 diabetes mellitus	0.00161	0.00356	CcSEcCtD
Succinylcholine—Arrhythmia—Losartan—type 2 diabetes mellitus	0.00161	0.00356	CcSEcCtD
Succinylcholine—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.00159	0.0035	CcSEcCtD
Succinylcholine—Rash—Glipizide—type 2 diabetes mellitus	0.00158	0.00347	CcSEcCtD
Succinylcholine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00157	0.00347	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.00157	0.00347	CcSEcCtD
Succinylcholine—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.00157	0.00346	CcSEcCtD
Succinylcholine—Shock—Valsartan—type 2 diabetes mellitus	0.00156	0.00344	CcSEcCtD
Succinylcholine—Hypertension—Metformin—type 2 diabetes mellitus	0.00153	0.00337	CcSEcCtD
Succinylcholine—Urticaria—Glyburide—type 2 diabetes mellitus	0.00153	0.00337	CcSEcCtD
Succinylcholine—Myalgia—Metformin—type 2 diabetes mellitus	0.00151	0.00332	CcSEcCtD
Succinylcholine—Hypotension—Valsartan—type 2 diabetes mellitus	0.00148	0.00327	CcSEcCtD
Succinylcholine—Rash—Glimepiride—type 2 diabetes mellitus	0.00147	0.00324	CcSEcCtD
Succinylcholine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00147	0.00324	CcSEcCtD
Succinylcholine—Rash—Sitagliptin—type 2 diabetes mellitus	0.00147	0.00323	CcSEcCtD
Succinylcholine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00146	0.00323	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.00145	0.00319	CcSEcCtD
Succinylcholine—Hypertension—Irbesartan—type 2 diabetes mellitus	0.00144	0.00318	CcSEcCtD
Succinylcholine—Flushing—Ramipril—type 2 diabetes mellitus	0.00144	0.00317	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.00143	0.00315	CcSEcCtD
Succinylcholine—Myalgia—Irbesartan—type 2 diabetes mellitus	0.00142	0.00313	CcSEcCtD
Succinylcholine—Shock—Metformin—type 2 diabetes mellitus	0.00142	0.00313	CcSEcCtD
Succinylcholine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.00142	0.00312	CcSEcCtD
Succinylcholine—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.00138	0.00305	CcSEcCtD
Succinylcholine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.00137	0.00302	CcSEcCtD
Succinylcholine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.00137	0.00301	CcSEcCtD
Succinylcholine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.00136	0.00301	CcSEcCtD
Succinylcholine—Hypotension—Metformin—type 2 diabetes mellitus	0.00135	0.00298	CcSEcCtD
Succinylcholine—Shock—Irbesartan—type 2 diabetes mellitus	0.00134	0.00296	CcSEcCtD
Succinylcholine—Myalgia—Losartan—type 2 diabetes mellitus	0.00134	0.00295	CcSEcCtD
Succinylcholine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.00133	0.00293	CcSEcCtD
Succinylcholine—Rash—Bromocriptine—type 2 diabetes mellitus	0.00133	0.00292	CcSEcCtD
Succinylcholine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00133	0.00292	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.00132	0.0029	CcSEcCtD
Succinylcholine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.00128	0.00283	CcSEcCtD
Succinylcholine—Hypotension—Irbesartan—type 2 diabetes mellitus	0.00127	0.00281	CcSEcCtD
Succinylcholine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.00127	0.0028	CcSEcCtD
Succinylcholine—Shock—Losartan—type 2 diabetes mellitus	0.00126	0.00278	CcSEcCtD
Succinylcholine—Urticaria—Valsartan—type 2 diabetes mellitus	0.00126	0.00278	CcSEcCtD
Succinylcholine—Tachycardia—Losartan—type 2 diabetes mellitus	0.00125	0.00276	CcSEcCtD
Succinylcholine—Urticaria—Orlistat—type 2 diabetes mellitus	0.00125	0.00275	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.00124	0.00274	CcSEcCtD
Succinylcholine—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.00124	0.00273	CcSEcCtD
Succinylcholine—Rash—Glyburide—type 2 diabetes mellitus	0.00121	0.00267	CcSEcCtD
Succinylcholine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00121	0.00267	CcSEcCtD
Succinylcholine—Hypotension—Losartan—type 2 diabetes mellitus	0.0012	0.00264	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.00117	0.00258	CcSEcCtD
Succinylcholine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.00117	0.00258	CcSEcCtD
Succinylcholine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.00116	0.00255	CcSEcCtD
Succinylcholine—Urticaria—Metformin—type 2 diabetes mellitus	0.00115	0.00253	CcSEcCtD
Succinylcholine—Myalgia—Ramipril—type 2 diabetes mellitus	0.00115	0.00253	CcSEcCtD
Succinylcholine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.0011	0.00243	CcSEcCtD
Succinylcholine—Rash—Gliclazide—type 2 diabetes mellitus	0.00109	0.0024	CcSEcCtD
Succinylcholine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00109	0.0024	CcSEcCtD
Succinylcholine—Urticaria—Irbesartan—type 2 diabetes mellitus	0.00108	0.00239	CcSEcCtD
Succinylcholine—Shock—Ramipril—type 2 diabetes mellitus	0.00108	0.00239	CcSEcCtD
Succinylcholine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.00108	0.00238	CcSEcCtD
Succinylcholine—Tachycardia—Ramipril—type 2 diabetes mellitus	0.00107	0.00237	CcSEcCtD
Succinylcholine—Hypotension—Ramipril—type 2 diabetes mellitus	0.00103	0.00227	CcSEcCtD
Succinylcholine—Urticaria—Losartan—type 2 diabetes mellitus	0.00102	0.00225	CcSEcCtD
Succinylcholine—Body temperature increased—Losartan—type 2 diabetes mellitus	0.00101	0.00224	CcSEcCtD
Succinylcholine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.001	0.00221	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.001	0.00221	CcSEcCtD
Succinylcholine—Rash—Valsartan—type 2 diabetes mellitus	0.001	0.0022	CcSEcCtD
Succinylcholine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.001	0.0022	CcSEcCtD
Succinylcholine—Rash—Orlistat—type 2 diabetes mellitus	0.000989	0.00218	CcSEcCtD
Succinylcholine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000988	0.00218	CcSEcCtD
Succinylcholine—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000945	0.00208	CcSEcCtD
Succinylcholine—Rash—Metformin—type 2 diabetes mellitus	0.000911	0.00201	CcSEcCtD
Succinylcholine—Dermatitis—Metformin—type 2 diabetes mellitus	0.00091	0.00201	CcSEcCtD
Succinylcholine—Urticaria—Ramipril—type 2 diabetes mellitus	0.000874	0.00193	CcSEcCtD
Succinylcholine—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.00087	0.00192	CcSEcCtD
Succinylcholine—Rash—Irbesartan—type 2 diabetes mellitus	0.00086	0.00189	CcSEcCtD
Succinylcholine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000859	0.00189	CcSEcCtD
Succinylcholine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000811	0.00179	CcSEcCtD
Succinylcholine—Rash—Losartan—type 2 diabetes mellitus	0.000809	0.00178	CcSEcCtD
Succinylcholine—Dermatitis—Losartan—type 2 diabetes mellitus	0.000808	0.00178	CcSEcCtD
Succinylcholine—Rash—Ramipril—type 2 diabetes mellitus	0.000694	0.00153	CcSEcCtD
Succinylcholine—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000693	0.00153	CcSEcCtD
Succinylcholine—BCHE—Metabolism—LPL—type 2 diabetes mellitus	4.65e-05	0.000153	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—CYP3A4—type 2 diabetes mellitus	4.63e-05	0.000152	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—CCR5—type 2 diabetes mellitus	4.61e-05	0.000152	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—C3—type 2 diabetes mellitus	4.57e-05	0.00015	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—C3—type 2 diabetes mellitus	4.55e-05	0.00015	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—GCG—type 2 diabetes mellitus	4.55e-05	0.00015	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—SLC2A4—type 2 diabetes mellitus	4.55e-05	0.00015	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—ADCY5—type 2 diabetes mellitus	4.55e-05	0.00015	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	4.54e-05	0.000149	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—GPX1—type 2 diabetes mellitus	4.53e-05	0.000149	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—EDNRB—type 2 diabetes mellitus	4.52e-05	0.000149	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—C3—type 2 diabetes mellitus	4.51e-05	0.000148	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	4.48e-05	0.000147	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	4.42e-05	0.000145	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—CD36—type 2 diabetes mellitus	4.41e-05	0.000145	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	4.4e-05	0.000145	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	4.4e-05	0.000145	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	4.4e-05	0.000145	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PSMD6—type 2 diabetes mellitus	4.39e-05	0.000145	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—HTR2C—type 2 diabetes mellitus	4.39e-05	0.000145	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	4.36e-05	0.000144	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PPP2CA—type 2 diabetes mellitus	4.36e-05	0.000144	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	4.35e-05	0.000143	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	4.35e-05	0.000143	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—AGT—type 2 diabetes mellitus	4.34e-05	0.000143	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—AGT—type 2 diabetes mellitus	4.33e-05	0.000142	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	4.28e-05	0.000141	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—AGT—type 2 diabetes mellitus	4.28e-05	0.000141	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—EDNRA—type 2 diabetes mellitus	4.27e-05	0.000141	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	4.27e-05	0.00014	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CYBA—type 2 diabetes mellitus	4.27e-05	0.00014	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—CALM1—type 2 diabetes mellitus	4.25e-05	0.00014	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CYBA—type 2 diabetes mellitus	4.25e-05	0.00014	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	4.23e-05	0.000139	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	4.21e-05	0.000139	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CYBA—type 2 diabetes mellitus	4.21e-05	0.000139	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	4.19e-05	0.000138	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—MTHFR—type 2 diabetes mellitus	4.18e-05	0.000138	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	4.18e-05	0.000138	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—GHRL—type 2 diabetes mellitus	4.17e-05	0.000137	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PLAT—type 2 diabetes mellitus	4.17e-05	0.000137	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PLAT—type 2 diabetes mellitus	4.16e-05	0.000137	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—GHRL—type 2 diabetes mellitus	4.16e-05	0.000137	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	4.14e-05	0.000136	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CALCA—type 2 diabetes mellitus	4.12e-05	0.000136	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PLAT—type 2 diabetes mellitus	4.12e-05	0.000136	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—GHRL—type 2 diabetes mellitus	4.12e-05	0.000136	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CALCA—type 2 diabetes mellitus	4.11e-05	0.000135	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PPARA—type 2 diabetes mellitus	4.1e-05	0.000135	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CALCA—type 2 diabetes mellitus	4.07e-05	0.000134	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	4.01e-05	0.000132	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	4e-05	0.000132	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—AGT—type 2 diabetes mellitus	3.97e-05	0.000131	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	3.96e-05	0.00013	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.92e-05	0.000129	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—GNB3—type 2 diabetes mellitus	3.92e-05	0.000129	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—CALM1—type 2 diabetes mellitus	3.91e-05	0.000129	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—HMOX1—type 2 diabetes mellitus	3.91e-05	0.000129	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—APOE—type 2 diabetes mellitus	3.89e-05	0.000128	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	3.88e-05	0.000128	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	3.87e-05	0.000127	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	3.87e-05	0.000127	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	3.85e-05	0.000127	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—CAT—type 2 diabetes mellitus	3.85e-05	0.000127	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—APOA1—type 2 diabetes mellitus	3.85e-05	0.000127	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	3.83e-05	0.000126	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	3.82e-05	0.000126	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—GCG—type 2 diabetes mellitus	3.82e-05	0.000126	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	3.82e-05	0.000126	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—GCG—type 2 diabetes mellitus	3.81e-05	0.000125	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PTPN1—type 2 diabetes mellitus	3.81e-05	0.000125	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	3.77e-05	0.000124	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—GCG—type 2 diabetes mellitus	3.77e-05	0.000124	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	3.76e-05	0.000124	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	3.74e-05	0.000123	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	3.74e-05	0.000123	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—APOB—type 2 diabetes mellitus	3.74e-05	0.000123	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	3.73e-05	0.000123	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	3.71e-05	0.000122	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	3.7e-05	0.000122	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—GSTM1—type 2 diabetes mellitus	3.64e-05	0.00012	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	3.57e-05	0.000118	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—LPL—type 2 diabetes mellitus	3.57e-05	0.000118	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—CCL2—type 2 diabetes mellitus	3.56e-05	0.000117	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	3.53e-05	0.000116	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	3.51e-05	0.000116	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	3.51e-05	0.000115	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—AKT2—type 2 diabetes mellitus	3.5e-05	0.000115	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—ADCY5—type 2 diabetes mellitus	3.5e-05	0.000115	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	3.5e-05	0.000115	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—GPX1—type 2 diabetes mellitus	3.48e-05	0.000115	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	3.47e-05	0.000114	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	3.46e-05	0.000114	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—CD36—type 2 diabetes mellitus	3.39e-05	0.000112	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PPARG—type 2 diabetes mellitus	3.39e-05	0.000112	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PPP2CA—type 2 diabetes mellitus	3.35e-05	0.00011	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—INS—type 2 diabetes mellitus	3.33e-05	0.00011	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	3.32e-05	0.000109	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	3.31e-05	0.000109	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—GNB3—type 2 diabetes mellitus	3.29e-05	0.000108	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—GNB3—type 2 diabetes mellitus	3.28e-05	0.000108	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	3.28e-05	0.000108	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—GNB3—type 2 diabetes mellitus	3.25e-05	0.000107	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MMP3—type 2 diabetes mellitus	3.25e-05	0.000107	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—AVP—type 2 diabetes mellitus	3.25e-05	0.000107	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—AVP—type 2 diabetes mellitus	3.24e-05	0.000107	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MMP3—type 2 diabetes mellitus	3.24e-05	0.000107	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—IGF2—type 2 diabetes mellitus	3.23e-05	0.000106	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IGF2—type 2 diabetes mellitus	3.22e-05	0.000106	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	3.22e-05	0.000106	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—MTHFR—type 2 diabetes mellitus	3.22e-05	0.000106	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	3.21e-05	0.000106	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—AVP—type 2 diabetes mellitus	3.21e-05	0.000106	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MMP3—type 2 diabetes mellitus	3.21e-05	0.000106	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IGF2—type 2 diabetes mellitus	3.19e-05	0.000105	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	3.19e-05	0.000105	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	3.18e-05	0.000105	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	3.18e-05	0.000105	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PPARA—type 2 diabetes mellitus	3.16e-05	0.000104	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	3.14e-05	0.000104	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—APOB—type 2 diabetes mellitus	3.14e-05	0.000103	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—APOB—type 2 diabetes mellitus	3.13e-05	0.000103	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	3.13e-05	0.000103	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IGF1R—type 2 diabetes mellitus	3.12e-05	0.000103	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—APOB—type 2 diabetes mellitus	3.1e-05	0.000102	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—EDN1—type 2 diabetes mellitus	3.09e-05	0.000102	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	3.09e-05	0.000102	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—EDN1—type 2 diabetes mellitus	3.08e-05	0.000101	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—AGT—type 2 diabetes mellitus	3.06e-05	0.000101	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—ALB—type 2 diabetes mellitus	3.05e-05	0.0001	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—EDN1—type 2 diabetes mellitus	3.05e-05	0.0001	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—CALM1—type 2 diabetes mellitus	3e-05	9.89e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—LPL—type 2 diabetes mellitus	3e-05	9.87e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—APOE—type 2 diabetes mellitus	2.99e-05	9.86e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—LPL—type 2 diabetes mellitus	2.99e-05	9.83e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—APOA1—type 2 diabetes mellitus	2.96e-05	9.75e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—LPL—type 2 diabetes mellitus	2.96e-05	9.74e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.93e-05	9.66e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.92e-05	9.63e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PIK3R1—type 2 diabetes mellitus	2.92e-05	9.6e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—NOS3—type 2 diabetes mellitus	2.92e-05	9.6e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.9e-05	9.53e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.81e-05	9.26e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.8e-05	9.23e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.78e-05	9.14e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.76e-05	9.09e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.75e-05	9.06e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.73e-05	8.97e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—C3—type 2 diabetes mellitus	2.7e-05	8.88e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—C3—type 2 diabetes mellitus	2.69e-05	8.85e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PTGS2—type 2 diabetes mellitus	2.67e-05	8.78e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—C3—type 2 diabetes mellitus	2.66e-05	8.77e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PPARG—type 2 diabetes mellitus	2.61e-05	8.59e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.57e-05	8.47e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.57e-05	8.45e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.56e-05	8.44e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—AGT—type 2 diabetes mellitus	2.56e-05	8.44e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.56e-05	8.42e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—INS—type 2 diabetes mellitus	2.56e-05	8.42e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—AGT—type 2 diabetes mellitus	2.56e-05	8.41e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.54e-05	8.36e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.53e-05	8.34e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—AGT—type 2 diabetes mellitus	2.53e-05	8.33e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.52e-05	8.3e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.51e-05	8.27e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—LEP—type 2 diabetes mellitus	2.51e-05	8.27e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—APOE—type 2 diabetes mellitus	2.51e-05	8.27e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—LEP—type 2 diabetes mellitus	2.5e-05	8.24e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—APOE—type 2 diabetes mellitus	2.5e-05	8.24e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.49e-05	8.19e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.48e-05	8.18e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—APOE—type 2 diabetes mellitus	2.48e-05	8.16e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—LEP—type 2 diabetes mellitus	2.48e-05	8.16e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.47e-05	8.15e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.45e-05	8.07e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.37e-05	7.8e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.36e-05	7.77e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—ALB—type 2 diabetes mellitus	2.35e-05	7.72e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.34e-05	7.7e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PIK3R1—type 2 diabetes mellitus	2.24e-05	7.39e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—NOS3—type 2 diabetes mellitus	2.24e-05	7.39e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.24e-05	7.38e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.23e-05	7.35e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.21e-05	7.28e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—INS—type 2 diabetes mellitus	2.15e-05	7.06e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—INS—type 2 diabetes mellitus	2.14e-05	7.04e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—INS—type 2 diabetes mellitus	2.12e-05	6.97e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.11e-05	6.95e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.1e-05	6.93e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.08e-05	6.86e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.08e-05	6.83e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.07e-05	6.83e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.07e-05	6.81e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.07e-05	6.81e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.07e-05	6.8e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.06e-05	6.78e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PTGS2—type 2 diabetes mellitus	2.05e-05	6.76e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.05e-05	6.75e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.05e-05	6.74e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.04e-05	6.71e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.97e-05	6.49e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.96e-05	6.47e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.95e-05	6.41e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.88e-05	6.2e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.88e-05	6.2e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.88e-05	6.18e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.88e-05	6.18e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.86e-05	6.12e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.86e-05	6.12e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.77e-05	5.83e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—RELA—type 2 diabetes mellitus	1.77e-05	5.81e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.75e-05	5.76e-05	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.61e-05	5.31e-05	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.61e-05	5.29e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.6e-05	5.26e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.59e-05	5.24e-05	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.59e-05	5.24e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.59e-05	5.23e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.58e-05	5.21e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.58e-05	5.19e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.57e-05	5.16e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.51e-05	4.97e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.5e-05	4.95e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.49e-05	4.92e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.49e-05	4.91e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.49e-05	4.9e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.47e-05	4.85e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.46e-05	4.82e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.46e-05	4.81e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.45e-05	4.76e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.39e-05	4.58e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—SRC—type 2 diabetes mellitus	1.39e-05	4.57e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.37e-05	4.52e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.36e-05	4.46e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.35e-05	4.45e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—AKT1—type 2 diabetes mellitus	1.34e-05	4.42e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.34e-05	4.41e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.24e-05	4.1e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.24e-05	4.08e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.23e-05	4.04e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.22e-05	4.02e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.22e-05	4e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.2e-05	3.97e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—AKT1—type 2 diabetes mellitus	1.03e-05	3.4e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	9.38e-06	3.09e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IL6—type 2 diabetes mellitus	9.35e-06	3.08e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	9.26e-06	3.05e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.65e-06	2.85e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.62e-06	2.84e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.54e-06	2.81e-05	CbGpPWpGaD
